Login to Your Account

Protection, Not Plumbing

New Approach Counteracts Stroke's Inflammation Piece

By Anette Breindl

Tuesday, July 26, 2011
Genentech Inc.'s tissue plasminogen activator (tPA), the only FDA-approved stroke drug, works by getting rid of the blood clot that is blocking blood flow.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription